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Abstract 
The apple (Malus ×domestica) cultivar Santana was shown to have a low 
allergenicity in a previously reported clinical trial. A protocol was developed to 
validate these results outside a clinical setting and to market the Santana as a 
hypoallergenic apple for large-scale consumption. This protocol was designed to 
ensure safe consumption of the Santana by consumers suffering from apple allergy. 
We tested the protocol in a pilot in 100 supermarket stores and evaluated in an 
internet-based survey with 295 respondents. Forty-one percent of the consumers 
with an apple allergy did not have an allergic reaction to the Santana. Only five 
percent of the allergic consumers that tried the Santana reported a strong allergic 
reaction. In concordance with this, the majority (78%) of the mild apple allergic 
consumers appreciated the Santana. The developed protocol is considered suitable 
for safe consumption of the Santana providing that information about the possibility 
of having an allergic reaction among consumers with a mild apple allergy is added to 
the label. 
 
INTRODUCTION 
About 2% of the population in Northern and Central Europe suffers from allergy 
to apple (Kootstra et al., 2007). The majority of these people suffer from a type of food 
allergy called oral allergy syndrome (OAS; Ortolani et al., 1988). The primary measure to 
deal with this allergy is to avoid eating fresh apples (Kootstra et al., 2007). This limits 
their normal dietary intake, which is not an ideal situation because apples contribute to a 
well-balanced and a healthy diet. 
Products that have a reduced allergenicity are called hypoallergenic. Consumption 
of such products results in a reduced allergic reaction or no allergic reaction in part of the 
consumers that react to the allergenic counterparts. The Dutch apple cultivar Santana was 
identified as hypoallergenic in a screening test among 21 apple cultivars using the prick to 
prick method and in a small-scale Double Blind Placebo Controlled Food Challenge 
(Bolhaar et al., 2005). Kootstra et al. (2007) confirmed these results in an open challenge 
and found that eight out of fifteen (53%) apple allergic patients did not develop any 
allergy complaints to the Santana. This differed significantly from the number of subjects 
who reacted to the apple cultivars Topaz (7%) and Golden Delicious (7%). In addition, 
four out of seven individuals that did react to the Santana experienced symptoms that 
were less severe than after consumption of the other two cultivars. Seventy-three percent 
of the test subjects stated that they would eat the Santana apple in the future.  
This study examines whether the Santana is suitable for marketing and 
consumption by apple allergic consumers using a special protocol. 
 
MATERIALS AND METHODS 
A protocol was developed to ensure that the Santana was made available for 
consumers with apple allergy in a medical, legal, logistic and commercial warranted way.  
The protocol was established in cooperation with the Dutch Food Allergy 
Foundation and with scientists in the field of allergy. The protocol was put in practice in 
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cooperation with the Dutch supermarket chain Albert Heijn. 
The information leaflet that was enclosed with the product redirected consumers to 
an internet page that provided additional information on apple allergy. The consumers 
were then prompted to fill in a survey. The survey included items on the severity of the 
apple allergy in general, the occurrence of an allergic reaction to the Santana, the severity 
of the symptoms in case an allergic reaction had occurred, the appreciation of the 
Santana, the use of allergy medication after eating Santana, and the consultation of a 
family doctor/allergologist before eating the Santana.  
 
RESULTS AND DISCUSSION 
 
The Protocol 
The following measures were included in the protocol:  
1. Measures to prevent mixing of the Santana with other apple cultivars. Mixing should 
be prevented throughout the production chain in order to avoid exposure of apple 
allergic consumers to cultivars which do induce an allergic reaction. The following 
steps were taken: exclusion of Santana orchards with pollinators in the Santana rows, 
storage in separate storage houses and packaging of the Santana prior to the shipment 
to selling in the stores. Special instructions were given to the workers involved to avoid 
mixing with other apples. 
2. Measures to restrict consumption of the Santana to consumers with a mild apple 
allergy. Previous studies showed that the Santana is not allergenic to part of the apple 
allergic consumers. Others with an apple allergy are still expected to have an allergic 
reaction to the Santana. Therefore, people who suffer from a severe allergic reaction to 
apples and who experience swelling responses or worse were strongly advised not to 
try the Santana. The package of the Santana read on the label: “suitable for people with 
a mild apple allergy; first read the enclosed information leaflet”. 
3. Measures to minimize the consequences of having an allergic reaction to the Santana 
(restriction to mild was considered insufficient to guarantee the absence or a sufficient 
reduction of all allergic reactions). Some patients with a mild apple allergy will still 
have an allergic reaction to the Santana. Therefore, an extra safety precaution was 
required to minimize the consequences of an allergic reaction: the enclosed information 
leaflet, included an appeal to follow a safe testing procedure. This step-wise procedure 
was described on the leaflet and could be carried out by consumers themselves at 
home. 
 
Consumer Survey 
The survey was completed by 295 consumers with an apple allergy who had all 
tried the Santana. The results in Table 1 show that the majority of these respondents 
classified themselves as having a mild or moderate apple allergy.  
Information about the reaction to the Santana is presented in Table 2. The most 
important observations are: 
1. The percentage of consumers who could eat the Santana without having an allergic 
reaction was highest in the “mild” apple allergy class (52%).  
2. The percentage of consumers who could eat the Santana without having an allergic 
reaction in the “moderate” and “severe” classes were lower (35 to 32%). 
3. The majority (78 to 84%) of the consumers in all apple allergy classes appreciated 
(score 5-7) the Santana. 
4. Experiencing an allergic reaction or not, had a large influence on appreciation. All 
consumers that had no allergic reaction to the Santana appreciated the Santana. 
The severity of the allergic reaction to the Santana among the consumers that did 
experience an allergic reaction was generally mild. Only five percent of the consumers 
reported having a strong allergic reaction, while four percent of the consumers used 
allergy medication after consumption of the Santana. Three percent of the respondents 
consulted a family doctor before eating the Santana. 
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The protocol covered the measurements that could be taken in terms of product 
responsibility on the part of the retailer especially the avoidance of severe allergic 
reactions occurring . Some consumers with a severe allergy did, however, try the Santana. 
Consumers have their own responsibilities to act on the suggestions that were provided 
with the product. 
 
CONCLUSIONS 
The results from the sales pilot indicated that the applied protocol was suitable to 
allow safe consumption of the Santana by apple allergic consumers. The majority of these 
consumers appreciated the Santana, although a considerable number of them still had a 
mild allergic reaction to the Santana. The step-wise testing protocol minimizes the 
consequences of these reactions. Information about the possibility of the occurrence of an 
allergic reaction in individuals that have a mild apple allergy should be added to the 
information label, as omitting this information may raise false expectations. 
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Tables 
 
Table 1. Number of respondents in the consumer survey, divided according to the self-
reported severity of the allergic reaction to apple in general. 
____________________________________________________________________ 
Classification Description1 Number of Percentage (%) 
apple allergy  respondents     
____________________________________________________________________ 
Mild Itching and irritation     77  26 
Moderate Slight swelling    187  63 
Severe Severe swelling      31  11 
 and shortness of breath 
Very severe 2 Life threatening      0    0 
 symptoms 
1 Reference to mouth, lips, tong, nose, eyes and throat  
2 The application of this protocol is restricted to the Netherlands, Belgium and Luxemburg. In these North-
West European countries, most people who suffer from apple allergy have a relative mild form of allergy. 
The allergy class “very severe” is expected to be extremely rare among apple allergic consumers in these 
countries. In contrast, a type of apple allergy that is caused by lipid transfer proteins may result in very 
severe symptoms in southern Europe (Pastorello et al., 1999).  
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Table 2. Appreciation of the Santana by respondents with an apple allergy. Numbers in 
the table are percentages. 
____________________________________________________________ 
Allergic Appreciation   
reaction to of the Santana                 Classification apple allergy1_____ 
the Santana by consumers2 Mild  Moderate Severe 
                          (%)                  (%)                 (%) 
No        1-4     0    0    0    
No        5-7   52  35  32 
 
Yes        1-4   22  17  16 
Yes        5-7   26  48  52 
Total        1-4   22  17  16 
Total        5-7   78  83  84 
1 According to the classification in Table 1 
2 Scale 1 to 7 with “1” labeled as “no appreciation at all” and “7” labeled as “high appreciation” 
